{"id":"NCT02293460","sponsor":"Laboratoire français de Fractionnement et de Biotechnologies","briefTitle":"Efficacy and Safety Study of I10E in Treatment of Patients With CIDP","officialTitle":"An International, Multicentre, Efficacy and Safety Study of I10E in Initial and Maintenance Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-05","primaryCompletion":"2017-09-29","completion":"2017-09-29","firstPosted":"2014-11-18","resultsPosted":"2020-03-09","lastUpdate":"2021-01-27"},"enrollment":44,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Inflammatory Demyelinating Polyradiculoneuropathy"],"interventions":[{"type":"DRUG","name":"I10E","otherNames":[]}],"arms":[{"label":"I10E Arm","type":"EXPERIMENTAL"}],"summary":"Primary objective:\n\nTo assess the efficacy of I10E in improving the disability of patients with CIDP.\n\nSecondary objective:\n\nTo assess the safety of I10E in patients with CIDP.","primaryOutcome":{"measure":"Efficacy Endpoint: Responder Rate at End of Study","timeFrame":"24 weeks after first treament injection","effectByArm":[{"arm":"Full Analysis Set","deltaMin":32,"sd":null}],"pValues":[{"comp":"OG000","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":33,"countries":["France","Italy","Spain","Tunisia","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":43},"commonTop":["Headache","Pyrexia","Influenza","Nausea","Myalgia"]}}